LSI INDUSTRIES INC Income Taxes Disclosure
NOTE 13 — INCOME TAXES
The following information is provided for the years ended June 30, 2025, and 2024:
|
(In thousands) |
2025 |
2024 |
||||||
|
Components of income (loss) before income taxes: |
||||||||
|
United States |
$ | 30,083 | $ | 32,295 | ||||
|
Foreign |
2,955 | 804 | ||||||
|
Income before income taxes |
$ | 33,038 | $ | 33,099 | ||||
|
Provision for income taxes |
||||||||
|
U.S. Federal |
$ | 8,403 | $ | 6,909 | ||||
|
Foreign |
700 | (30 | ) | |||||
|
State and local |
1,933 | 2,851 | ||||||
|
Total current |
$ | 11,036 | $ | 9,730 | ||||
|
Deferred |
(2,381 | ) | (1,608 | ) | ||||
|
Total provision for income taxes |
$ | 8,655 | $ | 8,122 | ||||
|
(In thousands) |
2025 |
2024 |
||||||
|
Reconciliation to federal statutory rate: |
||||||||
|
Federal statutory rate |
21.0 | 21.0 | ||||||
|
State and local taxes, net of federal benefit |
3.5 | 4.2 | ||||||
|
Foreign operations |
(0.1 | ) | (0.5 | ) | ||||
|
Federal tax credits |
(0.9 | ) | (1.1 | ) | ||||
|
Officer's Compensation |
1.8 | 1.9 | ||||||
|
Transaction costs |
0.7 | - | ||||||
|
Uncertain tax position activity |
0.4 | 0.5 | ||||||
|
Stock-based compensation |
(2.8 | ) | (2.3 | ) | ||||
|
Tax rate changes |
- | - | ||||||
|
Other |
2.6 | 0.8 | ||||||
|
Effective tax rate |
26.2 | 24.5 | ||||||
The components of deferred income tax assets and (liabilities) at June 30, 2025, and 2024 are as follows:
|
Components of deferred income tax assets and liabilities |
|||||||||
|
(In thousands) |
2025 |
2024 |
|||||||
|
Uncertain tax positions |
$ | 241 | $ | 241 | |||||
|
Reserves against current assets |
2,384 | 1,408 | |||||||
|
Accrued expenses |
3,962 | 3,029 | |||||||
|
Deferred compensation |
2,479 | 2,008 | |||||||
|
Stock-based compensation |
2,017 | 1,859 | |||||||
|
Capitalized R&D |
3,885 | 1,985 | |||||||
|
State net operating loss carryover and credits |
108 | 120 | |||||||
|
Lease Liability |
4,841 | 4,187 | |||||||
|
Canadian NOL |
- | 313 | |||||||
|
U.S. Federal net operating loss carryover and credits |
- | 52 | |||||||
|
Deferred income tax asset before valuation allowance |
19,917 | 15,202 | |||||||
|
Valuation allowance |
(108 | ) | (108 | ) | |||||
|
Deferred income tax asset |
19,809 | 15,094 | |||||||
|
Goodwill, acquisition costs and intangible assets |
(7,578 | ) | (3,977 | ) | |||||
|
Depreciation |
(3,436 | ) | (2,048 | ) | |||||
|
Right of Use Asset |
(4,702 | ) | (4,149 | ) | |||||
|
Deferred income tax liability |
|
(15,716 | ) | (10,174 | ) | ||||
|
Net deferred income tax asset |
$ | 4,093 | $ | 4,920 | |||||
The Company has deferred tax assets for US research and development credits of $0 and $0.1 million at June 30, 2025, and June 30, 2024, respectively. The Company has Canadian net operating loss carry forward deferred tax assets of $ 0.1 and $ million at June 30, 2025, and June 30, 2024, respectively.
The Company has state net operating loss carryovers and tax credit deferred tax assets of $0 and $0.1 million at June 30, 2025, and June 30, 2024, respectively. A valuation allowance of $0.1 million exists at June 30, 2025, against Oregon tax credits not expected to be used. The Oregon credits are otherwise expected to expire over a 4-year period beginning June 30, 2027.
At June 30, 2025, tax, interest, and penalties, net of potential federal tax benefits, were $1.8 million, $0.3 million, and $0.2 million, respectively, of the total reserve for uncertain tax positions of $ 2.3 million. The entire uncertain tax position of $ 1.8 million net of federal tax benefit, would impact the effective tax rate if recognized. An uncertain tax position and tax indemnification receivable of $ 1.1 million was recognized as a result of the CBH acquisition. The liability for uncertain tax position is included in Other Long-Term Liabilities.
At June 30, 2024, tax, interest, and penalties, net of potential federal tax benefits, were $0.6 million, $0.3 million, and $0.2 million, respectively, of the total reserve for uncertain tax positions of $1.1 million. The entire uncertain tax position of $0.6 million, net of federal tax benefit, would impact the effective tax rate if recognized.
The Company is recording estimated interest and penalties related to potential underpayment of income taxes as a component of tax expense in the Consolidated Statements of Operations. The Company recognized a $0.1 million net tax expense/(benefit) in both fiscal 2025 and fiscal 2024, related to the change in reserves for uncertain tax positions. The Company recognized interest net of federal benefit and penalties of $12,000 and $21,000, respectively, in fiscal 2025, and $17,000 and $37,000, respectively, in fiscal 2024. The reserve for uncertain tax positions is not expected to change significantly in the next twelve months.
The tax activity in the liability for uncertain tax positions was as follows:
| (In thousands) |
2025 |
2024 |
||||||
| Balance at the beginning of the fiscal year | $ | 825 | $ | 656 | ||||
|
Decreases - tax positions in prior period |
(101 | ) | (63 | ) | ||||
|
Increase - tax positions from acquired company |
1,149 | - | ||||||
|
Increase - tax positions in current period |
213 | 232 | ||||||
|
Balance at end of the fiscal year |
$ | 2,086 | $ | 825 | ||||
The Company files a consolidated federal income tax return in the United States, and files various combined and separate tax returns in several state and local jurisdictions, and also in Canada, Mexico, Jamaica, Barbados, and Puerto Rico. In general, the Company is no longer subject to U.S. Federal, state, and local tax examinations by tax authorities for fiscal years ending prior to June 30, 2022.
On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the U.S. The OBBBA includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. There are a variety of effective dates in the Act and only certain key provisions with financial reporting implications are expected to affect our financial statements for the year ending June 30, 2026. We expect to monetize our capitalized R&D deferred tax asset of $3,885 in the next fiscal year as a result of the recently enacted legislation.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Sep 11, 2025 | Showing above |
| 2024 | Sep 11, 2024 | |
| 2023 | Sep 8, 2023 | |
| 2022 | Sep 9, 2022 | |
| 2021 | Sep 10, 2021 | |
| 2020 | Sep 11, 2020 | |
| 2019 | Sep 6, 2019 | |
| 2018 | Sep 11, 2018 | |
| 2017 | Sep 8, 2017 | |
| 2016 | Sep 7, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.